Pancreaticoduodenectomy With or Without Preoperative Hyperbaric Oxygen Therapy
Status:
Enrolling by invitation
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the safety, tolerability and toxicity of
preoperative HBOT in patients undergoing a pancreaticoduodenal resection for premalignant and
malignant tumors of the common bile duct, periampullary and duodenum.